comparemela.com
Home
Live Updates
NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Advanced Solid Tumors at the 2024 American Society of Clinical Oncology Annual Meeting : comparemela.com
NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Advanced Solid Tumors at the 2024 American Society of Clinical Oncology Annual Meeting
NKGen Biotech, Inc. announced an online publication, titled ?Interim Analysis of a Phase I Study using Cryopreserved Non-genetically Modified Allogeneic Natural Killer Cells With Enhanced Cytotoxicity...
Related Keywords
Illinois
,
United States
,
Chicago
,
Mccormick Place
,
American
,
,
Nkgen Biotech Inc
,
Mccormick Place Convention Center
,
American Society Of Clinical Oncology
,
Interim Analysis
,
Phasei Study
,
Advanced Solid Tumors
,
Clinical Oncology
,
Annual Meeting
,
comparemela.com © 2020. All Rights Reserved.